FCER1A and asthma: Having found that BDCA1+ DCs in human airways can be identified by their co-expression of FcεRI and MHCII, we examined the prevalence of BDCA1+ DCs in asthma by employing immunofluorescence microscopy of bronchial biopsies using FcεRI and MHCII antibodies.